Sulfonylureas (glipizide, glyburide, glimepiride) cause non-glucose-dependent insulin release, meaning they push insulin out regardless of blood sugar level
Side Effects of SEMA-Q 0.5mg Injection While SEMA-Q is generally well-tolerated, it can cause some side effects, including: Nausea or vomiting Diarrhea Abdominal pain Decreased appetite Constipation In rare cases, serious side effects may occur, such as pancreatitis , kidney problems , or allergic reactions
The mechanism involves multiple complex pathways, including ferroptosis signaling
In 2023, the Saudi Food and Drug Authority (SFDA) implemented the Guideline for Registration of Human Medicinal Products, 2023 issued by the Saudi Food and Drug Authority, which introduced streamlined procedures for the approval of GLP-1 agonists